Cubist Systematic Strategies, LLC Orchard Therapeutics PLC Transaction History

Cubist Systematic Strategies, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.16 - $2.23 $20,383 - $39,185	-17,572 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.24 - $4.29 $39,361 - $75,383	17,572 New	17,572 $40,000
Q1 2021 May 17, 2021	SELL	$4.39 - $9.08 $48,430 - $100,170	-11,032 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.86 - $5.07 $42,583 - $55,932	11,032 New	11,032 $48,000
Q3 2020 Nov 16, 2020	SELL	$4.11 - $6.45 $192,232 - $301,679	-46,772 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$5.75 - $11.99 $268,939 - $560,796	46,772 New	46,772 $281,000
Q4 2019 Feb 14, 2020	SELL	$10.15 - $15.58 $6,932 - $10,641	-683 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$11.88 - $16.72 $8,114 - $11,419	683 New	683 $8,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.